Results 11 to 20 of about 191,751 (308)
Acta Medica Iranica, 2021 Thyroid malignancies are found in 7% to 15% of all thyroid nodules. Immunohistochemical markers, including CK19, HBME-1and TROP2, have shown an effective role in identifying these malignancies.
Masoud Mohebbi +4 more
doaj +1 more source
Concomitant bilateral papillary thyroid carcinoma and parathyroid adenoma
Case Reports in Clinical Practice, 2022 Thyroid malignant neoplasms are the most prevalent cancer of the endocrine system, and their concurrence with parathyroid neoplasms is extremely rare.
Reza Hajebi +2 more
doaj +1 more source
Galectin-3 Immunohistochemical Expression in Thyroid Neoplasms [PDF]
Journal of Clinical and Diagnostic Research, 2015 Background: Galectin-3 has been implicated in the regulation of cellular growth, differentiation and malignant transformation in various organs including thyroid gland. It has been extensively studied as an immunohistochemical (IHC) marker in thyroid
B S Sumana +2 more
doaj +1 more source
New biomarkers: prospect for diagnosis and monitoring of thyroid disease
Frontiers in Endocrinology, 2023 After the metabolic syndrome and its components, thyroid disorders represent the most common endocrine disorders, with increasing prevalence in the last two decades.
Mirjana T. Macvanin +7 more
doaj +1 more source
Diagnostic role of immunohistochemical markers CK19 and CD56 in thyroid neoplasms
MGM Journal of Medical Sciences, 2023 Introduction: Thyroid cancer is the most common type of endocrine cancer, with an increasing prevalence. The possibility of a malignant neoplasm is the primary concern in people with thyroid nodules. The presence of a plethora of variants complicates the
Pallavi Priyadarshini +2 more
doaj +1 more source
Combined Cyclin D2 and Protein Convertase 2 Genes in Differentiating Various Follicularpatterned Lesions and Neoplasms of the Thyroid: A Cross-sectional Study [PDF]
Journal of Clinical and Diagnostic Research, 2023 Introduction: A pretherapeutic distinction between benign and malignant thyroid nodules is critical for the clinical management of patients presenting with thyroid nodules.
Prasanna Venkadesa Perumal +4 more
doaj +1 more source
Morphological features of thyroid benign focal neoplasms in Graves’ disease
Mìžnarodnij Endokrinologìčnij Žurnal, 2022 Background. The morphology of the thyroid in Graves’ disease (GD) can be quite diverse: in most cases there is a diffuse enlargement of the thyroid gland (diffuse goiter), in some cases it is not increased, and in some patients there are focal neoplasms (
Yu.V. Buldygina +5 more
doaj +1 more source
Study of nuclear morphometry in the cytologic evaluation of thyroid neoplasms
Journal of Pathology of Nepal, 2023 Background: Nuclear morphometry is purported to allow better differentiation between various thyroid lesions beyond what is offered by conventional cytology.
Joyce Thomas +2 more
doaj +1 more source
National Journal of Laboratory Medicine, 2019 Introduction: Errors in categorization of thyroid neoplasms as benign or malignant has management implications. In several studies Galectin-3 was one of the most reliable markers for malignancy in thyroid.
Pallavi Vijay Borkar +2 more
doaj +1 more source
Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option? [PDF]
, 2014 BACKGROUND: Identification of the best management strategy for nodules with Thy3 cytology presents particular problems for clinicians. This study investigates the ability of clinical, cytological and sonographic data to predict malignancy in ...
CALO', PIETRO GIORGIO +6 more
core +1 more source